Building Compliant MedTech Software in Australia: The Real Technical and Regulatory Path

Building medical software in Australia means you’re not just writing code-you’re operating inside a regulated framework that touches everything from your architecture to your support team. Get it wrong, and you’re looking at expensive rewrites, delayed launches, or worse. Get it right from the start, and you move faster than competitors still figuring out the rules.

This isn’t theoretical. We’ve worked with Australian founders building health-adjacent products, and the ones who understood compliance early shipped faster and raised capital with fewer questions. The ones who treated it as an afterthought paid for it in time and money.

What Actually Makes Software “Medical” in Australia

The Therapeutic Goods Administration (TGA) is your regulatory body. But here’s the thing-not every health app needs TGA approval. Understanding where your product sits is the first real decision you need to make.

Software falls into TGA’s scope if it claims to diagnose, treat, prevent, or monitor a disease or condition. A fitness app that counts steps? Probably not regulated. A tool that interprets blood glucose readings and suggests insulin adjustments? Definitely is. The grey zone is where most founders get stuck.

You can submit a request to the TGA asking whether your specific product requires approval-a formal letter asking for clarification. It takes 3-4 weeks usually, costs nothing, and saves months of wasted development. Do this before you lock in your technical architecture.

Your Compliance Stack Will Affect Your Code

This is the part founders often miss. Compliance isn’t just paperwork bolted on at the end. It shapes how you actually build.

If you’re building a Class II or Class III medical device (most diagnostic or monitoring software), you’ll need:

• Version control with full audit trails. Every commit, every rollback, every deployed version needs to be documented and traceable. GitHub Enterprise with proper branch protection and signed commits. Not optional.
• Change management process. You can’t just push features whenever. Changes need approval, testing, documentation. This typically adds 2-3 weeks to your release cycle once you’re live.
• Automated testing infrastructure. Manual testing doesn’t cut it. You need documented test cases, coverage tracking, and regression testing for every release. Budget 25-35% of development time for this.
• Data security architecture. Encryption in transit and at rest, role-based access control, audit logging of all data access. This isn’t a feature; it’s foundational.
• Incident response and post-market surveillance. You need a process to track, investigate, and report adverse events. This means infrastructure to log what users do, not just what the system does.

These aren’t boxes to tick. They’re real architectural decisions that affect your development speed and infrastructure costs. A fintech we worked with underestimated this and spent 6 weeks retrofitting logging into a system that wasn’t built for it.

The Real Budget Numbers

Let’s talk money. Building MedTech in Australia costs more than a standard B2B SaaS product. Here’s a rough breakdown:

1. Regulatory consultation and documentation (AUD 15,000-40,000). You need a TGA-experienced consultant to review your submission, your quality management system, and your risk analysis. This isn’t a one-time cost-expect to budget for it across your MVP phase and again before you go live.
2. Quality management system setup (AUD 10,000-25,000). Software, templates, training. This is how you document everything-design decisions, testing, changes. Systems like MasterControl or Veeva exist for this; they’re expensive but necessary for Class II+ devices.
3. Development time for compliance-first architecture (20-40% overhead). Building with version control, automated testing, and audit logging from day one takes longer than a typical MVP. If your standard MVP takes 200 hours, budget 240-280 hours.
4. Third-party security audits (AUD 8,000-20,000). The TGA expects you to validate your security. A professional penetration test or security audit before submission is standard.
5. Submission and approval (AUD 0-50,000+). The TGA doesn’t charge submission fees, but if you need a notified body assessment for Class III devices, that’s 40,000-100,000 AUD and takes 3-6 months.

Total rough range for an MVP: AUD 50,000-200,000 in compliance-related costs alone, depending on your device class. This is on top of your actual development budget.

What Your Documentation Burden Actually Looks Like

The TGA doesn’t just want code. They want evidence that you built your product safely and that you know what you built.

You’ll need:

• A Clinical Evaluation Report (what clinical evidence supports your claims)
• A Risk Management Report (what could go wrong and how you prevent it)
• A Quality Management System document (how you control changes, testing, and releases)
• Software development documentation (design specs, test plans, traceability matrices)
• Summary of Safety and Performance (a plain-English overview for regulators)

This documentation doesn’t exist in isolation. Every line of code, every test case, every design decision needs to be traceable back to your requirements and forward to your testing. If you change a feature, you document why, test it, and log the change. This traceability matrix is where many teams stumble.

Start this documentation from day one. Don’t treat it as a final sprint. The teams that ship fastest are the ones writing documentation as they code, not the ones trying to reverse-engineer it after launch.

Speed Without Corners Cut

Here’s the actual competitive advantage: building compliance into your development process from the start doesn’t slow you down compared to building fast and fixing it later. It’s the same speed or faster because you’re not rewriting, re-testing, and re-documenting.

The TGA expects your MVP to be better documented than a typical tech MVP. Accept that. Build accordingly. Your real timeline isn’t slowed by compliance-it’s set by how well you understand your regulatory pathway before you start.

If you’re building MedTech in Australia and want to get the regulatory and technical strategy right before you sink time and money into development, talk to Amora about your build. We’ve built systems for Australian founders that ship fast and pass regulatory review.

Start with clarity. Document your path. Build smart. That’s how you move markets in MedTech.